You’ve probably started hearing more about peptide therapy — in functional medicine offices, in conversations about longevity and performance, and increasingly in mainstream health coverage. If your first reaction was “what exactly is a peptide?” you’re not alone. The term gets used a lot, often without much explanation of what these compounds actually are, how they work, or why they’ve become one of the more talked-about tools in advanced health optimization. The short answer is that peptides are signaling molecules — short chains of amino acids that your body uses to communicate between cells and regulate nearly every biological process, from growth hormone release to immune function to tissue repair. Peptide therapy uses these compounds, either identical to or closely modeled after ones your body naturally produces, to restore or amplify specific physiological functions that have declined with age, stress, or dysfunction. The longer answer is worth understanding — because peptide therapy is not a single treatment. It’s a category of therapies, each targeting a different system and serving a different clinical purpose. Knowing what peptides are, how they work, what specific peptides are used and why, and how to evaluate whether any of them are appropriate for you is the foundation of making an informed decision about this area of care.
What You Need to Know
Peptides are not new. Your body produces thousands of them and has been using them as biological messengers since before you were born. What is relatively new is our ability to isolate, synthesize, and administer specific peptides therapeutically — in doses and combinations designed to target specific outcomes. Some peptide therapies are FDA-approved medications. Others are available through compounding pharmacies and prescribed off-label by physicians for health optimization purposes. The landscape is evolving rapidly, and the regulatory environment around specific peptides has shifted in recent years. What makes peptide therapy different from conventional pharmaceuticals is its mechanism: peptides work by restoring or amplifying your body’s own signaling pathways rather than overriding them. They tend to be highly specific in their targets, which is part of why they’ve attracted interest from both researchers and clinicians looking for more precise tools in the health optimization space. Because the field is moving quickly and because the quality, availability, and legal status of specific peptides can change, it’s critical that any peptide therapy be initiated under physician oversight with appropriate evaluation — not purchased online without medical guidance.
What Are Peptides, Exactly?
A peptide is a chain of amino acids — the same building blocks that make up proteins. The distinction is length: peptides are shorter chains (typically 2 to 50 amino acids), while proteins are longer. Because of their smaller size, peptides can be absorbed and used by the body in ways that larger proteins cannot, making them effective as signaling molecules and therapeutic agents. Your body naturally produces hundreds of peptides that regulate virtually every biological system. Insulin is a peptide. Glucagon is a peptide. The hormones that signal your pituitary gland to release growth hormone — growth hormone-releasing hormone (GHRH) and ghrelin — are peptides. The compounds your immune system uses to coordinate responses are peptides. The molecules that regulate your sleep-wake cycle, your hunger, your tissue repair response, and your inflammatory cascade are, in many cases, peptides. Therapeutic peptides are either identical to these naturally occurring compounds or are modified versions designed to be more stable, more potent, or more targeted than the body’s own versions. When administered correctly, they work by binding to the receptors your body already has for those signals, activating the same downstream pathways — only with more precision and consistency than a declining or dysregulated system can produce on its own.
How Peptide Therapy Works
Peptide therapy works by delivering specific signaling molecules that bind to target receptors in specific tissues or glands and trigger a defined biological response. Because peptides are highly specific — a given peptide will only bind to the receptor it’s designed for — the effects tend to be targeted rather than systemic in the way that broader hormonal or pharmaceutical interventions can be. The most clinically developed area of peptide therapy involves growth hormone secretagogues — peptides that stimulate the pituitary gland to produce and release more of your own growth hormone. This approach is distinct from administering growth hormone directly: rather than introducing exogenous growth hormone into the body, these peptides restore the pituitary’s own output, preserving the natural pulsatile rhythm of growth hormone release and the feedback mechanisms that regulate it. Other peptides work through different mechanisms: modulating inflammation, accelerating tissue repair, supporting immune function, improving metabolic signaling, or enhancing cognitive function. Each peptide has a specific target and a defined mechanism, which is why the selection of which peptide (or peptides) to use is a clinical decision that should be driven by your specific needs, lab findings, and health goals.
Commonly Used Peptides in Clinical Practice
Growth Hormone Secretagogues
This is the most established category of peptide therapy. Growth hormone secretagogues stimulate the pituitary gland to produce and release growth hormone, addressing the significant decline in growth hormone output that occurs with age. Growth hormone plays a central role in body composition, fat metabolism, muscle maintenance, bone density, immune function, sleep quality, and tissue repair.
- Sermorelin: A synthetic analog of growth hormone-releasing hormone (GHRH). Sermorelin stimulates the pituitary to produce growth hormone in a physiologic, pulsatile pattern. It has a long track record of clinical use, is generally well-tolerated, and has been one of the most widely used peptides in anti-aging and functional medicine settings.
- CJC-1295: A longer-acting GHRH analog that sustains growth hormone stimulation over a longer window than sermorelin. Often combined with ipamorelin for a more robust and sustained growth hormone pulse.
- Ipamorelin: A selective growth hormone secretagogue that stimulates growth hormone release without significantly affecting cortisol or prolactin — a meaningful advantage over older secretagogues. Ipamorelin is frequently combined with CJC-1295 because they work through complementary mechanisms, producing a synergistic increase in growth hormone output.
- Tesamorelin: An FDA-approved GHRH analog originally developed for HIV-associated lipodystrophy that has since attracted interest for its effects on visceral fat reduction and cognitive function. Tesamorelin has more clinical trial data behind it than most other peptides in this category.
- MK-677 (Ibutamoren): Technically not a peptide but a ghrelin mimetic that stimulates growth hormone and IGF-1. While not injectable like the others, it has been used in clinical research and is orally bioavailable. Its regulatory status is distinct from the peptides above.
Tissue Repair and Recovery Peptides
- BPC-157 (Body Protection Compound): A peptide derived from a protein found in gastric juice that has demonstrated significant tissue-healing effects in animal studies, including accelerated healing of tendons, ligaments, muscle, and gut tissue. BPC-157 has attracted significant interest for injury recovery, gut repair, and inflammatory conditions. Human clinical trial data is more limited than the animal literature, but clinical experience has been substantial.
- TB-500 (Thymosin Beta-4): A naturally occurring peptide involved in cell migration, tissue regeneration, and inflammation modulation. TB-500 is studied for its role in wound healing, recovery from musculoskeletal injuries, and cardiovascular tissue repair. Often used in combination with BPC-157 for enhanced recovery effects.
Immune and Thymic Peptides
- Thymosin Alpha-1 (TA1): A peptide produced by the thymus gland that plays a central role in immune regulation. Thymosin alpha-1 has been used in clinical settings internationally for immune support, has a long research history, and has been studied in the context of chronic infections, autoimmune conditions, and cancer support.
Metabolic Peptides
- GLP-1 Receptor Agonists (e.g., semaglutide, tirzepatide): These are FDA-approved peptide-based medications that have transformed the treatment of type 2 diabetes and obesity. They work by mimicking the GLP-1 hormone to regulate blood sugar, reduce appetite, slow gastric emptying, and support significant weight loss. While mainstream in their indications, they belong to the broader family of therapeutic peptides and represent the most clinically validated end of the peptide spectrum.
Cognitive and Neuroprotective Peptides
- Dihexa: A peptide studied for its effects on cognitive function and neuroplasticity, with research suggesting significant potency as a cognitive enhancer. Research is earlier-stage compared to the secretagogue class.
- Semax and Selank: Peptides with nootropic and anxiolytic properties, developed in Russia and used clinically there for decades. Research in English-language literature is growing but remains more limited than for other categories.
Who May Benefit from Peptide Therapy
Peptide therapy is not a one-size-fits-all intervention. The decision about whether any specific peptide is appropriate — and which one — depends on your symptoms, your lab findings, your health history, and your treatment goals. Patients who are most commonly evaluated for peptide therapy include those who:
- Are experiencing the effects of declining growth hormone: poor sleep, reduced muscle mass, increased body fat (particularly visceral fat), slower recovery from exercise or injury, reduced energy, and declining skin and tissue quality
- Are struggling with weight loss resistance that has not responded adequately to nutrition, exercise, and hormone optimization alone
- Have chronic or slow-healing musculoskeletal injuries, gut dysfunction, or tissue damage that has not responded to conventional treatment
- Are managing immune dysregulation, chronic infections, or autoimmune conditions and are looking for adjunctive support
- Are pursuing a comprehensive longevity or health optimization strategy and want to address growth hormone decline as part of a broader protocol
Candidacy is evaluated through a combination of symptom assessment, lab work (including IGF-1 as a proxy marker for growth hormone output), and a thorough health history. Not every patient with these symptoms needs peptide therapy, and not every patient is an appropriate candidate. A responsible evaluation comes first.
How Peptide Therapy Is Administered
Most therapeutic peptides are administered via subcutaneous injection — small needles injected into the fat layer just beneath the skin, similar to how insulin is administered. The injections are simple enough that most patients self-administer at home after a brief instruction. Some peptides are available in oral, nasal, or topical forms, though injectable delivery generally provides more reliable absorption and bioavailability for most compounds. Dosing schedules vary by peptide. Growth hormone secretagogues are typically administered at night before sleep to coincide with the body’s natural overnight growth hormone pulse. Some protocols call for daily injections; others use cycling schedules (5 days on, 2 days off, for example) to prevent receptor desensitization. Your provider will specify the schedule appropriate for your protocol. Because most therapeutic peptides used in the optimization space are compounded — not commercially manufactured — the quality and sterility of the source pharmacy matters significantly. A responsible practice uses only accredited compounding pharmacies that meet USP 797 sterile compounding standards.
Safety
Your safety comes first. Peptide therapy carries a different risk profile than conventional pharmaceuticals, but it is not without considerations. Some important points: Growth hormone secretagogues should not be used by individuals with active malignancy, as growth hormone signaling can potentially stimulate tumor growth. A personal or family history of cancer requires careful risk-benefit discussion before initiating any growth hormone-stimulating therapy. Peptides that stimulate growth hormone can increase IGF-1 levels, which should be monitored periodically during therapy. Elevated IGF-1 has been associated with increased cancer risk in some studies, which is why ongoing lab monitoring is an essential part of responsible long-term use. The regulatory landscape for compounded peptides has shifted in recent years. Certain peptides that were widely available through compounding pharmacies have had their status changed by the FDA. Your provider should be current on the regulatory status of any peptide being prescribed and should source only from licensed, accredited compounding pharmacies. Side effects vary by peptide and dose. Growth hormone secretagogues can cause temporary water retention, increased hunger, fatigue, and vivid dreams — particularly at the start of therapy. Most of these effects are dose-dependent and resolve with adjustment. Injection site reactions (mild redness or irritation) are common and typically minor. Seek medical attention if you experience signs of an allergic reaction, significant swelling, persistent pain at injection sites, or any unexpected symptoms after initiating therapy.
Next Steps
At our practice, peptide therapy is one component of a comprehensive health optimization strategy — not a standalone intervention. We evaluate every patient through our VIP Cellular Health Assessment before recommending any peptide protocol, ensuring that your therapy is based on your actual lab findings, health history, and goals rather than a generic approach. We offer both in-person care in Central Ohio and telemedicine consultations nationwide.
Sources & Citations
Frequently Asked Questions
What is peptide therapy?
Peptide therapy is the therapeutic use of short amino acid chains — called peptides — to restore or amplify specific biological signaling pathways that have declined with age, stress, or dysfunction. Your body naturally produces hundreds of peptides that regulate growth hormone release, tissue repair, immune function, metabolism, and cognitive function. Therapeutic peptides are either identical to these naturally occurring compounds or modified versions designed to be more stable or targeted. They work by binding to the receptors your body already has for those signals, activating the same downstream pathways with more precision than a declining system can achieve on its own.
Are peptides the same as hormones?
Many hormones are peptides — insulin, glucagon, and growth hormone-releasing hormone are all peptides. But not all peptides are hormones. The term “peptide” refers to the molecular structure (a chain of amino acids), while “hormone” refers to function (a molecule that travels through the bloodstream to regulate distant tissues). In clinical practice, peptide therapy typically refers to a specific category of compounds used to optimize physiological function — most commonly growth hormone secretagogues and tissue repair peptides — rather than to hormone replacement therapy, which addresses sex hormones like estrogen, progesterone, and testosterone directly.
What is the difference between peptide therapy and HRT?
Hormone replacement therapy (HRT or BHRT) directly replaces hormones your body is no longer producing at adequate levels — estrogen, progesterone, testosterone. Peptide therapy works differently: rather than replacing a hormone, most peptides work by stimulating your body to produce more of its own hormones or by activating specific repair and signaling pathways. Growth hormone secretagogues, for example, don’t add growth hormone to your body — they signal your pituitary gland to produce more of its own. The two approaches are complementary rather than competing, and many patients benefit from both as part of a comprehensive protocol.
Is peptide therapy FDA-approved?
Some peptides are FDA-approved medications. GLP-1 receptor agonists like semaglutide and tirzepatide are FDA-approved for type 2 diabetes and obesity. Tesamorelin is FDA-approved for HIV-associated lipodystrophy. Sermorelin was FDA-approved for growth hormone deficiency in children before being discontinued as a commercial product (it remains available through compounding pharmacies). Many other peptides used in the optimization space are prescribed off-label and obtained through licensed compounding pharmacies rather than commercial manufacturing. Compounded peptides are not FDA-approved as finished products, though they are legal when prescribed by a physician and compounded by an accredited pharmacy.
What are the benefits of peptide therapy?
The potential benefits depend on which peptide is used and what it is targeting. Growth hormone secretagogues are most commonly associated with improvements in body composition (reduced visceral fat, increased lean muscle), sleep quality, energy, recovery from exercise, skin quality, and immune function. BPC-157 and TB-500 are used for accelerated tissue repair and gut healing. Thymosin alpha-1 is used for immune support. GLP-1 peptides produce significant weight loss and metabolic improvements. The key is matching the right peptide to the right indication based on your specific lab findings and health goals — not pursuing peptides based on general wellness marketing.
What does peptide therapy feel like? What can I expect?
Most patients notice the earliest effects of growth hormone secretagogue therapy in sleep quality — typically within the first two to four weeks. Deeper sleep, more vivid dreams, and waking more rested are common early signs that growth hormone output is increasing. Energy improvements tend to follow, along with gradual changes in body composition over two to four months of consistent use. Tissue repair peptides like BPC-157 often produce more rapid effects in the specific area being treated. Initial side effects, particularly with growth hormone secretagogues, can include temporary water retention and increased appetite, which are dose-dependent and typically resolve within the first few weeks.
How long do you take peptide therapy?
Duration depends on the peptide and your goals. Growth hormone secretagogue protocols are often run in cycles — commonly three to six months on, followed by a break — to prevent receptor downregulation and allow the body’s own systems to reset. Some patients use them for longer periods with periodic monitoring. Tissue repair peptides like BPC-157 are typically used for a defined treatment period tied to the healing goal. GLP-1 medications may be used indefinitely as long as the indication remains. Your provider will recommend a protocol duration appropriate for your specific therapy and goals, with ongoing lab monitoring to guide decisions.
Are there risks or side effects with peptide therapy?
Yes, and they vary by peptide. Growth hormone secretagogues can cause water retention, increased hunger, fatigue, and vivid dreams — particularly at the start of therapy. These effects are typically dose-dependent and temporary. More importantly, growth hormone-stimulating therapy should not be used by anyone with active malignancy, as growth hormone signaling may potentially stimulate tumor growth. IGF-1 levels should be monitored periodically. Injection site reactions are common and usually minor. Because most therapeutic peptides in the optimization space are compounded, pharmacy quality matters significantly. A responsible prescriber will use only USP-compliant accredited compounding pharmacies and will conduct appropriate pre-treatment screening and ongoing monitoring.
Can peptide therapy help with weight loss?
It depends on which peptides and what is driving the weight loss resistance. GLP-1 receptor agonists (semaglutide, tirzepatide) are among the most effective weight loss interventions available and are FDA-approved for obesity. Growth hormone secretagogues can improve body composition by reducing visceral fat and supporting lean muscle — changes that improve metabolic function over time. Neither approach replaces the foundational work of hormone optimization, nutrition, and resistance training, but for patients who have done that work and are still struggling, the right peptide can provide meaningful additional support. The decision about which approach fits your situation should be based on a comprehensive metabolic evaluation, not a one-size-fits-all recommendation.
Can peptide therapy be combined with BHRT?
Yes, and in many cases the combination is synergistic. BHRT addresses declining sex hormones — testosterone, estrogen, progesterone — that directly affect metabolic function, body composition, and quality of life. Peptide therapy can address growth hormone decline, tissue repair deficits, or metabolic signaling issues that sex hormone optimization alone doesn’t fully resolve. When both are clinically indicated and properly monitored, combining them addresses a broader range of the physiological changes that drive symptoms and health decline with age. The key is that both should be prescribed based on testing and evaluation — not stacked indiscriminately.
Do you offer telehealth appointments?
Yes. We offer telehealth consultations for patients who prefer virtual visits or live outside our local area. Lab kits can be mailed directly to you, and consultations, lab reviews, protocol design, and ongoing monitoring can all be managed via video appointments. We serve clients nationwide.
What happens in the discovery call?
The discovery call is a free, no-obligation conversation where we learn about your health history, current symptoms, and goals. We’ll discuss whether our approach — including whether peptide therapy may be relevant for your situation — is a good fit, and answer any questions you have about testing and the evaluation process. There’s no pressure — it’s simply an opportunity to find out if we’re the right team to help you understand your options and make an informed decision.
This content is for educational purposes and does not substitute personalized medical advice.
